Myelofibrosis Associated with Romiplostim Treatment in a Patient with Immune Thrombocytopenia

Immune thrombocytopenia is characterized by antibody-mediated platelet destruction and insufficient platelet production resulting in isolated thrombocytopenia in the absence of underlying cause. Despite many treatment options, low-to-intermediate rates of remission and high rates of resistance to tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez, Maria Fernanda, Freeman, Jonathan King
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420420/
https://www.ncbi.nlm.nih.gov/pubmed/22937324
http://dx.doi.org/10.1155/2012/318597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420420/
https://www.ncbi.nlm.nih.gov/pubmed/22937324
http://dx.doi.org/10.1155/2012/318597

Ejemplares similares